-
Part 1 | Session 6 Plenary Session 3: Using SGLT2 in your patients: practical considerations
-
Part 1 | Session 8 Plenary Session 4: Managing your HF patients with comorbidities (part 2)
-
Part 1 | Session 11 Plenary Session 5: Managing side effects of HF drugs
-
Part 1 | Session 12 Meet the expert: Sex differences in advanced heart failure
-
Part 1 | Session 13 Plenary Session 6: How to manage the obese patient with HF
-
Part 2 | Session 1 Plenary Session 7: New technologies to manage your patients
-
Part 2 | Session 3 Plenary Session 8: New technologies to treat your patients
-
Part 2 | Session 4 Plenary Session 9: Comparing European and US recent guidelines
-
Part 2 | Session 8 Plenary Session 11: Managing the HF patient with valvular heart disease
-
Part 2 | Session 10 Plenary Session 12: Managing the patient with worsening and advanced HF
e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.
Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.
For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day 1
Part 2
Day 2
Faculty Biographies
Yuhui Zhang
Dr Yuhui Zhang is vice director of the Heart Failure Center and HFCU at Beijing Fuwai hospital, National Center for Cardiovascular Diseases in China.
She is secretary-general of the Chinese Heart Failure Association, the China National Heart Failure Society, the National HF Quality Control, the HF Medical Consortium, the Heart Failure specialist center Project, the China International Heart Failure Congress and of the Heart Failure Forum of China Heart Congress.
Dr Yuhui Zhang is an Editorial Board member of Cardiac Failure Review and may be contactable here.
David Sim
Consultant
Overview
Dr David Sim is a senior consultant in the cardiology department at the National Heart Centre in Singapore.
Academic History
- Royal College of Physicians (UK) diploma, 2004
- Masters of Medicine (Internal Medicine), National University of Singapore, 2004
- Bachelor of Medicine and Surgery, National University of Singapore, 2004
Career Overview
Dr Sim is the director of both the heart failure programme and the clinical trial research office and plays an active role as coordinator in a number of major global heart failure trials. He is a committee member of the adult heart transplant programme in the NHCS and is the project director for the advanced care planning programme.1
He has worked as an associate professor at the…
Giuseppe Rosano
Consultant Cardiologist and Professor of Cardiology (Hon)
Giuseppe Rosano was born and raised in Vibo Valentia, Italy, where he developed an early interest in medicine and cardiovascular science. While detailed information about his family and early childhood is not widely published, his Italian background and international academic career reflect strong cultural roots combined with global engagement in cardiovascular medicine.
Academic History
Professor Rosano obtained his Medical Degree in Medicine and Surgery with full honours from La Sapienza University of Rome in 1988. He subsequently completed his specialisation in Cardiology in 1992. Following his clinical training, he pursued advanced academic and research qualifications in the United Kingdom, earning both an MSc and a PhD in Medical Sciences from Imperial College London. His postgraduate research focused on cardiovascular physiology and pharmacology, forming the foundation of his future work in heart failure and cardiac metabolism.
Vijay Chopra
Senior Director of Clinical Cardiology, Heart Failure and Research
Dr Vijay Chopra is the Senior Director of Clinical Cardiology, Heart Failure and Research in the Heart Failure Programme at the Max Super Specialty Hospital in Saket, New Delhi, India. He is considered a pioneer in preventive cardiology, and has worked extensively in the management of patients with advanced heart disease. He has been principal investigator of numerous international clinical trials.
Dr Chopra's research interests include preventive cardiology, heart failures and advanced heart diseases. He was awarded the Kutumbiah Prize in Clinical Medicine from CMC Vellore in 1972. He founded the Heart Failure Association of India (HFAI), and served as its first president from 2014 - 2019.
Dr Chopra has over 50 publications in peer-reviewed journals.
Dr Vijay Chopra is an Editorial Board member of Cardiac Failure Review and may be contacted
A John Camm
Professor of Clinical Cardiology
A. John Camm is a British cardiologist internationally recognised for his contributions to clinical cardiology and cardiac electrophysiology. He has spent the majority of his professional career in the United Kingdom and has been closely associated with St George’s, University of London, where he has lived and worked for many decades. Throughout his career, he has combined clinical practice, academic leadership, and international guideline development, becoming one of the most influential figures in modern arrhythmia management.
Academic History
Professor Camm undertook his medical education and postgraduate training in the United Kingdom, progressing through specialist training in internal medicine and cardiology before focusing on cardiac electrophysiology. He developed a strong academic foundation early in his career, which led to senior academic appointments in cardiovascular medicine.
He was appointed British Heart Foundation Professor of…